The Science of
Cellular Regeneration
Discover how we reverse biological aging without genetic modification
Our Technology
Prometheus Cells:
Your Body's Time Machine
Our proprietary autologous rejuvenated fibroblast (auto-rFib) technology transforms your own aged cells into their younger, more functional state. Unlike genetic modification or stem cell therapies, we work with your body's natural cellular mechanisms to restore youthful function.
Zero Genetic Modification
Pure epigenetic reprogramming preserves your genetic integrity while reversing cellular aging markers
90%+ Success Rate
Industry-leading efficiency in converting aged cells to their rejuvenated state
15-Day Transformation
Complete cellular rejuvenation achieved in just two weeks of specialized treatment
Our Advantages
Why Celljevity?
Key advantages of our autologous cell rejuvenation technology
No Genetic Modification
Pure epigenetic reprogramming preserves your DNA integrity while reversing aging markers
Proven Clinical Results
Demonstrated efficacy across multiple age-related conditions with peer-reviewed outcomes
Rapid Treatment
Complete cellular rejuvenation achieved in just 15 days of specialized treatment
GMP Certified Process
State-of-the-art facilities ensure the highest quality and safety standards
Personalized Medicine
Using your own cells eliminates rejection risk and ensures perfect compatibility
Scientific Excellence
Backed by publications in Nature, Science, and Cell journals
Treatment Journey
The Rejuvenation Process
From collection to treatment in five precise steps

Tissue Collection
A small 1cm² skin biopsy is collected from behind the ear under local anesthesia

Cell Isolation
Fibroblasts are isolated and expanded in our GMP-certified laboratories

Rejuvenation Protocol
Proprietary 15-day treatment reverses cellular aging markers to embryonic levels

Quality Validation
Single-cell RNA sequencing confirms successful rejuvenation before release

Therapeutic Delivery
20 billion rejuvenated cells delivered via targeted injection or IV infusion
Clinical Validation
Evidence-Based Results
Peer-reviewed outcomes from our comprehensive clinical trials
Clinical Success Rates by Condition
Key Clinical Outcomes
Alzheimer's Disease
37 patientsCognitive function preserved or improved in 89% of patients
24-month follow-up
Autoimmune Disorders
56 patients90% experienced significant symptom relief
18-month study
Osteoarthritis
80 patients67% showed measurable joint improvement
12-month trial
Global Collaboration
Research Partners
Working with world-class institutions to advance regenerative medicine

UCLA Medical Center
Los Angeles, CA

Tongji University School of Medicine
Shanghai, China

Shanghai Institute for Advanced Immunochemical Studies
Shanghai, China

Kunming Medical University
Kunming, China

Shanghai Academy of Science & Technology
Shanghai, China
Innovation Roadmap
The Future of
Regenerative Medicine
Pioneering the next generation of cellular therapies
Spinal Cord Repair
Early studies show promise in using rejuvenated cells to repair spinal cord injuries, potentially restoring function to paralyzed patients.
Organ Regeneration
We're developing protocols to regenerate damaged organ tissue, starting with liver and kidney applications for chronic disease patients.
AI-Powered Personalization
Machine learning algorithms will optimize treatment protocols for individual patients based on their unique cellular signatures.
Ready to Learn More?
Whether you're a researcher interested in collaboration or a patient seeking treatment, we're here to answer your questions.